Header Logo

BEVERLY CAROL HANDY

TitleAssociate Professor
InstitutionMD Anderson
DepartmentLaboratory Medicine
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Han CY, Lu KH, Corrigan G, Perez A, Kohring SD, Celestino J, Bedi D, Bedia E, Bevers T, Boruta D, Carlson M, Holman L, Leeds L, Mathews C, McCann G, Moore RG, Schlumbrecht M, Slomovitz B, Tobias D, Williams-Brown Y, Bevers MW, Liu J, Gornet TG, Handy BC, Lu Z, Bedia JS, Skates SJ, Bast RC. Normal Risk Ovarian Screening Study: 21-Year Update. J Clin Oncol. 2024 Apr 01; 42(10):1102-1109. PMID: 38194613.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M, Celestino J, Guo J, Gornet TG, Soosaipillai A, Yang H, Doskocil SD, Lokshin AE, Handy BC, Diamandis EP, Moore RG, Lu KH, Lu Z, Anderson KS, Drescher CW, Skates SJ, Bast RC. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer. Br J Cancer. 2024 Mar; 130(5):861-868. PMID: 38195887; PMCID: PMC10912308.
      Citations:    Fields:    Translation:Humans
    3. Peacock WF, Baumann BM, Rivers EJ, Davis TE, Handy B, Jones CW, Hollander JE, Limkakeng AT, Mehrotra A, Than M, Cullen L, Dinkel-Keuthage C, Ziegler A. Using Sex-specific Cutoffs for High-sensitivity Cardiac Troponin T to Diagnose Acute Myocardial Infarction. Acad Emerg Med. 2021 04; 28(4):463-466. PMID: 32726505; PMCID: PMC8247402.
      Citations: 1     Fields:    Translation:Humans
    4. Wang W, Ding Y, Campbell A, Handy BC, Medeiros LJ, Lin P. Biclonal presentation of lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinaemia. Pathology. 2019 04; 51(3):340-343. PMID: 30846229.
      Citations:    Fields:    Translation:Humans
    5. Cao L, Lee CH, Ning J, Handy BC, Wagar EA, Meng QH. Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer. Arch Pathol Lab Med. 2018 09; 142(9):1106-1112. PMID: 29547000.
      Citations: 4     Fields:    Translation:Humans
    6. Peacock WF, Baumann BM, Bruton D, Davis TE, Handy B, Jones CW, Hollander JE, Limkakeng AT, Mehrotra A, Than M, Ziegler A, Dinkel C. Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome. JAMA Cardiol. 2018 02 01; 3(2):104-111. PMID: 29238804; PMCID: PMC5838590.
      Citations: 20     Fields:    Translation:Humans
    7. Xu JY, Handy B, Michaelis CL, Waguespack SG, Hu MI, Busaidy N, Jimenez C, Cabanillas ME, Fritsche HA, Cote GJ, Sherman SI. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer. J Clin Endocrinol Metab. 2016 11; 101(11):4461-4467. PMID: 27575943; PMCID: PMC5095245.
      Citations: 11     Fields:    Translation:HumansCells
    8. Cao L, Chen M, Phipps RA, Del Guidice RE, Handy BC, Wagar EA, Meng QH. Causes and impact of specimen rejection in a clinical chemistry laboratory. Clin Chim Acta. 2016 Jul 01; 458:154-8. PMID: 27166198.
      Citations: 1     Fields:    Translation:Humans
    9. Meng QH, Handy BC, Wagar EA. Falsely elevated tacrolimus concentrations on the Dimension Xpand. Clin Biochem. 2015 Nov; 48(16-17):1210. PMID: 26160209.
      Citations:    Fields:    Translation:Humans
    10. Giuliano M, Giordano A, Jackson S, De Giorgi U, Mego M, Cohen EN, Gao H, Anfossi S, Handy BC, Ueno NT, Alvarez RH, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination. Breast Cancer Res. 2014 Sep 16; 16(5):440. PMID: 25223629; PMCID: PMC4303121.
      Citations: 43     Fields:    Translation:HumansCells
    11. Meng QH, Handy B, Wagar E. A case of green blood. Clin Chem. 2014 Apr; 60(4):695-6. PMID: 24682689.
      Citations: 1     Fields:    Translation:Humans
    12. Meng QH, Handy B, Wagar EA. It's not easy being blue-green. Ann Lab Med. 2013 Nov; 33(6):457-8. PMID: 24205497; PMCID: PMC3819447.
      Citations:    Fields:    Translation:HumansCells
    13. Meng QH, Handy B, Wagar E. Confirmatory testing of urine ketones and bilirubin: still necessary? Arch Pathol Lab Med. 2013 Aug; 137(8):1028-9. PMID: 23899056.
      Citations:    Fields:    Translation:Humans
    14. Dean-Colomb W, Hess KR, Young E, Gornet TG, Handy BC, Moulder SL, Ibrahim N, Pusztai L, Booser D, Valero V, Hortobagyi GN, Esteva FJ. Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer. Breast Cancer Res Treat. 2013 Jan; 137(2):631-6. PMID: 23242617; PMCID: PMC3867793.
      Citations: 9     Fields:    Translation:Humans
    15. Paxton RJ, Garcia-Prieto C, Berglund M, Hernandez M, Hajek RA, Handy B, Brown J, Jones LA. A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors. Gynecol Oncol. 2012 Mar; 124(3):410-6. PMID: 22119991; PMCID: PMC3278555.
      Citations: 11     Fields:    Translation:HumansAnimals
    16. Giuliano M, Giordano A, Jackson S, Hess KR, De Giorgi U, Mego M, Handy BC, Ueno NT, Alvarez RH, De Laurentiis M, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res. 2011 Jun 15; 13(3):R67. PMID: 21699723; PMCID: PMC3218956.
      Citations: 93     Fields:    Translation:HumansCells
    17. Mego M, De Giorgi U, Dawood S, Wang X, Valero V, Andreopoulou E, Handy B, Ueno NT, Reuben JM, Cristofanilli M. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. Int J Cancer. 2011 Jul 15; 129(2):417-23. PMID: 20857493.
      Citations: 56     Fields:    Translation:HumansCells
    18. De Giorgi U, Mego M, Rohren EM, Liu P, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M, Ueno NT. 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer. J Nucl Med. 2010 Aug; 51(8):1213-8. PMID: 20660382.
      Citations: 22     Fields:    Translation:HumansCells
    19. Handy BC. Accelerating Development and Advancing Personalized Therapy (ADAPT) Congress. Washington, DC, USA, 22-25 September 2009. Biomark Med. 2010 Feb; 4(1):129-31. PMID: 20387309.
      Citations: 2     Fields:    Translation:HumansCells
    20. De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol. 2009 Jul 10; 27(20):3303-11. PMID: 19451443.
      Citations: 46     Fields:    Translation:HumansCells
    21. Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer. 2008 Nov 01; 113(9):2422-30. PMID: 18785255.
      Citations: 61     Fields:    Translation:HumansCellsCTClinical Trials
    22. Davis JW, Nakanishi H, Kumar VS, Bhadkamkar VA, McCormack R, Fritsche HA, Handy B, Gornet T, Babaian RJ. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. J Urol. 2008 Jun; 179(6):2187-91; discussion 2191. PMID: 18423725.
      Citations: 68     Fields:    Translation:HumansCells
    23. Yin CC, Lin P, Carney DA, Handy BC, Rassidakis GZ, Admirand JH, Keating MJ, Medeiros LJ. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol. 2005 Apr; 123(4):594-602. PMID: 15743747.
      Citations: 10     Fields:    Translation:Humans
    24. Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol. 2005 Feb; 123(2):200-5. PMID: 15842043.
      Citations: 16     Fields:    Translation:Humans
    25. Paul S, Karle S, Planque S, Taguchi H, Salas M, Nishiyama Y, Handy B, Hunter R, Edmundson A, Hanson C. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120. J Biol Chem. 2004 Sep 17; 279(38):39611-9. PMID: 15269209.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    26. Handy BC. Urinary beta2-microglobulin masquerading as a Bence Jones protein. Arch Pathol Lab Med. 2001 Apr; 125(4):555-7. PMID: 11260637.
      Citations:    Fields:    Translation:Humans
    27. Causes and impact of specimen rejection in a clinical chemistry laboratory. Clinica Chimica Acta. 458:154-158.
    28. Clinical applications of nanotechnology to cancer diagnostics and therapeutics. Journal of Clinical Ligand Assay. 29:124-129.
    29. The clinical utility of tumor markers. Laboratory Medicine. 40:99-103.
    30. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Annals of Oncology. 21:33-39.
    31. Detection and prognostic significance of circulating tumor cells in patients with metastatic thyroid cancer. Journal of Clinical Endocrinology and Metabolism. 101:4461-4467.
    32. Evaluation of potassium values in a cancer patient population. Laboratory Medicine. 36:95-97.
    HANDY's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (148)
    Explore
    _
    Co-Authors (29)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _